SCHEMBL31661677

SCHEMBL31661677

CC(C)c1ccccc1-c1ccc(-c2noc(-c3ccc(-c4nc(C(F)(F)F)cn4C)cc3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP1 O94782 12/20 0.52
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
S1PR1 P21453 2/20 0.42
WDR48 Q8TAF3 1/20 0.41
NPC1 O15118 3/20 0.41
NFKB1 P19838 3/20 0.41
RAB9A P51151 3/20 0.41
NFKB2 Q00653 3/20 0.41
RELA Q04206 3/20 0.41
CHUK O15111 1/20 0.40
TXNRD1 Q16881 1/20 0.40
NOX4 Q9NPH5 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661653 1.00 USP1 (0.52) USP1LMNATHRBS1PR1WDR48
SCHEMBL31661803 0.90 USP1 (0.58) USP1WDR48
SCHEMBL31661552 0.89 USP1 (0.48) USP1S1PR1WDR48NPC1NFKB1
SCHEMBL31661670 0.87 USP1 (0.54) USP1WDR48
SCHEMBL31661610 0.86 USP1 (0.47) USP1S1PR1WDR48NPC1NFKB1
SCHEMBL31661659 0.86 LMNA (0.55) LMNATHRBS1PR1NPC1NFKB1
SCHEMBL31661787 0.83 USP1 (0.44) USP1S1PR1SMN1; SMN2
SCHEMBL31661744 0.81 NR1H4 (0.50) LMNATHRBS1PR1NPC1NFKB1
SCHEMBL31661762 0.81 NR1H4 (0.50) LMNATHRBS1PR1NPC1NFKB1
SCHEMBL31661587 0.80 SMN1; SMN2 (0.56) USP1LMNATHRBS1PR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151705-A1 NOVEL INHIBITORS OF DNA DAMAGE REPAIR PATHWAY VRISE THERAPEUTICS, INC. (US) 2025-07-17 WO claimed
WO-2025151705-A1 NOVEL INHIBITORS OF DNA DAMAGE REPAIR PATHWAY VRISE THERAPEUTICS, INC. (US) 2025-07-17 WO disclosed